These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3965155)

  • 1. Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectum.
    Sarna G; Mitsuyasu R; Figlin R; Ambersley J; Groopman J
    Cancer Chemother Pharmacol; 1985; 14(1):12-4. PubMed ID: 3965155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-day schedule of vinzolidine, an oral vinca alkaloid, in a variety of tumors.
    Takasugi BJ; Robertone AB; Salmon SE; Jones SE; Alberts DS
    Invest New Drugs; 1984; 2(4):387-90. PubMed ID: 6096287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of vinzolidine.
    Budman DR; Schulman P; Marks M; Vinciguerra V; Weiselberg L; Kreis W; Degnan TJ
    Cancer Treat Rep; 1984; 68(7-8):979-82. PubMed ID: 6744350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule.
    Budman DR; Kreis W; Behr J; Schulman P; Lichtman S; Allen SL; Weiselberg L; Satterlee WG; Nelson RL; Vinciguerra V
    Invest New Drugs; 1990 Aug; 8(3):269-74. PubMed ID: 2272767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classic Kaposi's sarcoma with colonic involvement: a rare presentation with successful treatment with oral etoposide.
    Tas F; Keskin S; Yegen G; Gozubuyukoglu N
    J Cancer Res Ther; 2012; 8(1):112-3. PubMed ID: 22531526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.
    Adenis A; Pion JM; Fumoleau P; Pouillart P; Marty M; Giroux B; Bonneterre J
    Cancer Chemother Pharmacol; 1995; 35(6):527-8. PubMed ID: 7882462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
    TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
    J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS).
    Tas F; Sen F; Keskin S; Kilic L
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):789-92. PubMed ID: 22188463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Kaposi's sarcoma. Chemotherapy I.
    Vogel CL
    Antibiot Chemother (1971); 1981; 29():82-7. PubMed ID: 7027912
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
    Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
    AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel.
    Engin H; Celik I
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178. PubMed ID: 12069127
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of activity of Irinotecan in patients with advanced AIDS-related Kaposi's sarcoma.
    Vaccher E; di Gennaro G; Simonelli C; Schioppa O; Tirelli U;
    AIDS; 2005 Nov; 19(16):1915-6. PubMed ID: 16227802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.
    Rougier P; Bugat R; Douillard JY; Culine S; Suc E; Brunet P; Becouarn Y; Ychou M; Marty M; Extra JM; Bonneterre J; Adenis A; Seitz JF; Ganem G; Namer M; Conroy T; Negrier S; Merrouche Y; Burki F; Mousseau M; Herait P; Mahjoubi M
    J Clin Oncol; 1997 Jan; 15(1):251-60. PubMed ID: 8996150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
    Takasugi BJ; Jones SE; Robertone AB
    Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.